VSBC

VitaSpring Biomedical Co. Ltd. [VSBC] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

VSBC Stock Summary

In the News

VSBC Financial details

Company Rating
Neutral
Market Cap
3.3B
Income
0
Revenue
0
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
21 Dec 2022
P/E
2607.39
Forward P/E
-
PEG
-
P/S
608.29
P/B
2089.17
P/C
-
P/FCF
289018.5
Quick Ratio
1.97
Current Ratio
1.97
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
0
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-100%
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
35%
ROE
151%
ROC
0.72%
Gross Margin
37%
Oper. Margin
26%
Profit Margin
23%
Payout
-
Shs Outstand
206.52M
Shs Float
0
-
-
-
-
Target Price
-
52W Range
10.0-16.5
52W High
-
52W Low
-
RSI
-
Rel Volume
2.15
Avg Volume
93
Volume
-
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
1.188
-
-
Volatility
0%, 0%
Prev Close
-
Price
-
Change
-

VSBC Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-01-31

Metric History 2019-01-312020-01-312021-01-312022-01-31 2023-01-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
0000.030
Net income per share
0000.010
Operating cash flow per share
00000
Free cash flow per share
00000
Cash per share
00000
Book value per share
0000.010
Tangible book value per share
0000.010
Share holders equity per share
0000.010
Interest debt per share
00000
Market cap
22.89M22.89M1.09B2.88B0
Enterprise value
22.91M22.89M1.09B2.88B0
P/E ratio
-1.02K942.5-2.57K2.28K0
Price to sales ratio
1.33K1.51K4.4K513.750
POCF ratio
-668.48-218.04K-25.95K34K0
PFCF ratio
-668.48-218.04K-25.95K244.1K0
P/B Ratio
-3.31K-1.25K11.34K1.83K0
PTB ratio
-3.31K-1.25K11.34K1.83K0
EV to sales
1.33K1.51K4.4K513.810
Enterprise value over EBITDA
-1.04K-628.77-2.57K1.93K0
EV to operating cash flow
-669.02-218.04K-25.94K34.01K0
EV to free cash flow
-669.02-218.04K-25.94K244.13K0
Earnings yield
00000
Free cash flow yield
00000
Debt to equity
-2.65000.290
Debt to assets
1.61000.130
Net debt to EBITDA
-0.8300.110.240
Current ratio
0.5502.041.970
Interest coverage
00-634.9-627.590
Income quality
1.53-0.020.10.070
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
2.11.372.160.10
Research and developement to revenue
00000
Intangibles to total assets
00000
Capex to operating cash flow
000-0.860
Capex to revenue
000-0.010
Capex to depreciation
000-8.730
Stock based compensation to revenue
001.750.030
Graham number
000.010.030
ROIC
-1.963.75-4.410.50
Return on tangible assets
-1.960-2.250.350
Graham Net
00000
Working capital
-8.34K096.36K1.51M0
Tangible asset value
-6.92K096.36K1.58M0
Net current asset value
-8.34K096.36K1.04M0
Invested capital
-2.65000.290
Average receivables
0001.48M1.48M
Average payables
70500625.75K625.75K
Average inventory
7.15K4.25K72K72K0
Days sales outstanding
000191.960
Days payables outstanding
000128.850
Days of inventory on hand
895.310386.4700
Receivables turnover
0001.90
Payables turnover
0002.830
Inventory turnover
0.4100.9400
ROE
3.24-1.33-4.410.80
Capex per share
00000

Quarterly Fundamentals Overview

Last date of statement is 2023-10-31 for Q3

Metric History 2022-10-312023-01-312023-04-302023-07-31 2023-10-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
00000
Net income per share
00000
Operating cash flow per share
00000
Free cash flow per share
00000
Cash per share
00000
Book value per share
0.010000
Tangible book value per share
0.010000
Share holders equity per share
0.010000
Interest debt per share
00000
Market cap
3.07B0000
Enterprise value
3.07B0000
P/E ratio
-5.56K0000
Price to sales ratio
00000
POCF ratio
1.25M0000
PFCF ratio
1.25M0000
P/B Ratio
1.82K0000
PTB ratio
1.82K0000
EV to sales
00000
Enterprise value over EBITDA
-17.12K0000
EV to operating cash flow
1.25M0000
EV to free cash flow
1.25M0000
Earnings yield
00000
Free cash flow yield
00000
Debt to equity
0.20000
Debt to assets
0.130000
Net debt to EBITDA
-1.710000
Current ratio
4.330000
Interest coverage
-287.190000
Income quality
-0.020000
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
00000
Intangibles to total assets
00000
Capex to operating cash flow
00000
Capex to revenue
00000
Capex to depreciation
00000
Stock based compensation to revenue
00000
Graham number
0.010000
ROIC
-0.060000
Return on tangible assets
-0.060000
Graham Net
00000
Working capital
1.58M0000
Tangible asset value
1.68M0000
Net current asset value
1.29M0000
Invested capital
0.20000
Average receivables
2.07M1.01M000
Average payables
00000
Average inventory
-1.01M-1.01M000
Days sales outstanding
00000
Days payables outstanding
00000
Days of inventory on hand
-48.28K0000
Receivables turnover
00000
Payables turnover
00000
Inventory turnover
00000
ROE
-0.080000
Capex per share
00000

VSBC Frequently Asked Questions

What is VitaSpring Biomedical Co. Ltd. stock symbol ?

VitaSpring Biomedical Co. Ltd. is a US stock , located in Irvine of Ca and trading under the symbol VSBC

What is VitaSpring Biomedical Co. Ltd. stock quote today ?

VitaSpring Biomedical Co. Ltd. stock price is $- today.

Is VitaSpring Biomedical Co. Ltd. stock public?

Yes, VitaSpring Biomedical Co. Ltd. is a publicly traded company.

Something similar